We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, Health Canada, MHRA Jointly Specify ‘Good Machine Learning Practice’
FDA, Health Canada, MHRA Jointly Specify ‘Good Machine Learning Practice’
Devices that use artificial intelligence and machine learning should undergo testing that demonstrates their performance during clinically relevant conditions, the FDA, Health Canada and the UK’s Medicines and Healthcare products Regulatory Agency advised in a joint document on good machine learning practice (GMLP) released yesterday.